CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Larimar Therapeutics, Inc. Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.	United States of America	LRMR
LEAP THERAPEUTICS, INC. Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.	United States of America	LPTX
Lidds AB Develops oncology drugs using a technology for local, controlled, and sustained drug release.	Sweden	LIDDS
LigaChem Biosciences Inc. Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.	South Korea	141080
LIGAND PHARMACEUTICALS INC Acquires drug royalties and licenses proprietary technologies to biopharmaceutical partners.	United States of America	LGND
LIKE,Inc. Provides comprehensive lifestyle support in childcare, human resources, and nursing care services.	Japan	2462
Linical Co., Ltd. Global CRO providing full-service drug development support for biopharma companies.	Japan	2183
Linkers Corporation A technology matchmaking platform for manufacturers to solve challenges and foster innovation.	Japan	5131
Lipidor AB Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.	Sweden	LIPI
MAIA Biotechnology, Inc. Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.	United States of America	MAIA